BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · 4th Quarter - Termination

ACCELERON PHARMA INC

via ACCELERON PHARMA INC

4th Quarter (Oct 1 - Dec 31) · 2021Posted Jan 18, 2022Filing document ↗LDA record ↗

Expenses$20Kself-filed spend

Client

Name: ACCELERON PHARMA INC
Location: Massachusetts · United States of America

Registrant

Firm: ACCELERON PHARMA INC
Description: Medical research
Location: Cambridge, Massachusetts, United States of America

Lobbying activities

1 issue

Health Issues
The client is engaging on H.R. 3 - Lower Drug Costs Now Act and prescription drug pricing legislation generally.
LobbyistsGREG CHESMORE
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

ACCELERON PHARMA INC — Lobbying — Receipts Report